{
  "document_id": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement_Option Agreement",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_I/Development/HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement_Option Agreement.pdf",
  "text_length": 249416,
  "chunk_count": 329,
  "vector_store_path": "output/vector_stores/HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement_Option Agreement",
  "summary": "[***]  [***]  under this Agreement with respect to Licensed Compounds or Licensed Products that are [***] .\n6.15 No Other Compensation . Each Party hereby agrees that the terms of this Agreement fully define\nall consideration, compensation and benefits, monetary or otherwise, to be paid, granted or delivered by one Party to the other Party in\nconnection with the transactions contemplated herein. Neither Party previously has paid or entered into any other commitment to pay,\nwhether orally or in writing, any of the other Party\u2019s employees, directly or indirectly, any consideration, compensation or benefits,\nmonetary or otherwise, in connection with the transaction contemplated herein.\nARTICLE 7\nINTELLECTUAL PROPERTY\nINTELLECTUAL PROPERTY\n7.1 Ownership of Intellectual Property.\n7.1.1 Ownership of Technology. Subject to Section 3.8.2(c)  and Section 7.1.2 , as between the\n\nARTICLE 10\nREPRESENTATIONS AND WARRANTIES\n10.1 Mutual Representations and Warranties. Harpoon and AbbVie each represents and warrants to\nthe other, as of the Effective Date, as follows:\n10.1.1 Organization. It is a corporation duly incorporated, validly existing, and in good standing\nunder the laws of the jurisdiction of its incorporation, and has all requisite corporate power and authority, to execute, deliver, and\nperform this Agreement.\n10.1.2 Authorization.  The execution and delivery of this Agreement and the performance by it\nof the transactions contemplated hereby have been duly authorized by all necessary corporate action, and do not violate (a) such\nParty\u2019s charter documents, bylaws, or other organizational documents, (b) in any material respect, any agreement, instrument, or\ncontractual obligation to which such Party is bound, (c) any requirement of any Applicable Law, or (d) any order, writ, judgment,\n\n6.3.1 upon [***] Licensed Product, [***]\u037e and\n6.3.2 upon the First Commercial Sale for the first Licensed Product to achieve such [***],\n[***].\nEach milestone payment in this Section 6.3  shall be payable only upon the first achievement of such milestone and no amounts shall be\ndue for subsequent or repeated achievements of such milestone, whether for the same or a different Licensed Compound or  Licensed\nProduct. The maximum aggregate amount payable by AbbVie pursuant to this Section 6.3  is [***].\n6.4 Sales-Based Milestones.  In partial consideration of the rights granted by Harpoon to AbbVie\nhereunder and subject to the terms and conditions set forth in this Agreement, AbbVie shall pay to Harpoon the following non-\nrefundable milestone payments due within [***] after the end of the [***] in which such milestone was achieved for the aggregate\nsales of all Licensed Products in the Territory, calculated as follows:[***].\n\ncontract relating to voting rights or corporate governance, or otherwise\u037e or (b) the ownership, directly or indirectly, of more than fifty\npercent (50%) of the voting securities or other ownership interest of a Person (or, with respect to a limited partnership or other similar\nentity, its general partner or controlling entity). The Parties acknowledge that in the case of certain entities organized under the laws\nof certain countries outside of the United States, the maximum percentage ownership permitted by law for a foreign investor may be\nless than fifty percent (50%), and that in such case such lower percentage shall be substituted in the preceding sentence, provided\nthat such foreign investor has the power to direct the management or policies of such entity.\n1.17  \u201cAgreement \u201d has the meaning set forth in the preamble hereto.\n1.18 \u201cAlliance Manager \u201d has the meaning set forth in Section 2.2.5 .",
  "parties": "contract relating to voting rights or corporate governance, or otherwise\u037e or (b) the ownership, directly or indirectly, of more than fifty\npercent (50%) of the voting securities or other ownership interest of a Person (or, with respect to a limited partnership or other similar\nentity, its general partner or controlling entity). The Parties acknowledge that in the case of certain entities organized under the laws\nof certain countries outside of the United States, the maximum percentage ownership permitted by law for a foreign investor may be\nless than fifty percent (50%), and that in such case such lower percentage shall be substituted in the preceding sentence, provided\nthat such foreign investor has the power to direct the management or policies of such entity.\n1.17  \u201cAgreement \u201d has the meaning set forth in the preamble hereto.\n1.18 \u201cAlliance Manager \u201d has the meaning set forth in Section 2.2.5 .\n\n13.14 Further Assurance. Each Party shall duly execute and deliver, or cause to be duly executed and\ndelivered, such further instruments and do and cause to be done such further acts and things, including the filing of such assignments,\nagreements, documents, and instruments, as may be necessary or as the other Party may reasonably request in connection with this\nAgreement or to carry out more effectively the provisions and purposes hereof, or to better assure and confirm unto such other Party\nits rights and remedies under this Agreement.\n13.15 Relationship of the Parties. It is expressly agreed that Harpoon, on the one hand, and AbbVie,\non the other hand, shall be independent contractors and that the relationship between the Parties shall not constitute a partnership, joint\nventure, or agency, including for all tax purposes. Further, the Parties (and any successor, assignee, transferee, or Affiliate of a Party)\n\nventure, or agency, including for all tax purposes. Further, the Parties (and any successor, assignee, transferee, or Affiliate of a Party)\nshall not treat or report the relationship between the Parties arising under this Agreement as a partnership for United States tax\npurposes, without the prior written consent of the other Party unless required by a final \u201cdetermination\u201d as defined in Section 1313 of\nthe United States Internal Revenue Code of 1986, as amended. Neither Harpoon, on the one hand, nor AbbVie, on the other hand,\nshall have the authority to make any statements, representations, or commitments of any kind, or to take any action, which shall be\nbinding on the other, without the prior written consent of the other Party to do so. All persons employed by a Party shall be employees\nof such Party and not of the other Party and all costs and obligations incurred by reason of any such employment shall be for the\naccount and expense of such Party.\n\nwithheld, conditioned, or delayed, neither Party shall sell, transfer, assign, delegate, pledge, or otherwise dispose of, whether\nvoluntarily, involuntarily, by operation of law or otherwise, this Agreement or any of its rights or duties hereunder\u037e provided  that either\nParty may make such an assignment without the other Party\u2019s consent to its Affiliate or to a successor, whether in a merger, sale of\nstock, sale of assets or any other transaction, of the business to which this Agreement relates. With respect to an assignment to an\nAffiliate, the assigning Party shall remain responsible for the performance by such Affiliate of the rights and obligations hereunder.\nAny attempted assignment or delegation in violation of this Section 13.4  shall be void and of no effect. All validly assigned and\ndelegated rights and obligations of the Parties hereunder shall be binding upon and inure to the benefit of and be enforceable by and",
  "key_terms": "contractual obligation to which such Party is bound, (c) any requirement of any Applicable Law, or (d) any order, writ, judgment,\ninjunction, decree, determination, or award of any court or governmental agency presently in effect applicable to such Party.\n10.1.3 Binding Agreement.  This Agreement is a legal, valid, and binding obligation of such\nParty enforceable against it in accordance with its terms and conditions, subject to the effects of bankruptcy, insolvency, or other laws\nof general application affecting the enforcement of creditor rights, judicial principles affecting the availability of specific performance,\nand general principles of equity (whether enforceability is considered a proceeding at law or equity).\n10.1.4 No Inconsistent Obligation.  It is not under any obligation, contractual or otherwise, to\nany Person that conflicts with or is inconsistent in any material respect with the terms of this Agreement, or that would impede the\n\n[***]  [***]  under this Agreement with respect to Licensed Compounds or Licensed Products that are [***] .\n6.15 No Other Compensation . Each Party hereby agrees that the terms of this Agreement fully define\nall consideration, compensation and benefits, monetary or otherwise, to be paid, granted or delivered by one Party to the other Party in\nconnection with the transactions contemplated herein. Neither Party previously has paid or entered into any other commitment to pay,\nwhether orally or in writing, any of the other Party\u2019s employees, directly or indirectly, any consideration, compensation or benefits,\nmonetary or otherwise, in connection with the transaction contemplated herein.\nARTICLE 7\nINTELLECTUAL PROPERTY\nINTELLECTUAL PROPERTY\n7.1 Ownership of Intellectual Property.\n7.1.1 Ownership of Technology. Subject to Section 3.8.2(c)  and Section 7.1.2 , as between the\n\ntranslation, the English version shall control.\n13.11 Equitable Relief. Each Party acknowledges and agrees that the restrictions set forth in Section\n5.8 and Articles 7  and 9 are reasonable and necessary to protect the legitimate interests of the other Party and that such other Party\nwould not have entered into this Agreement in the absence of such restrictions, and that any breach or threatened breach of any\nprovision of such Section or Articles may result in irreparable injury to such other Party for which there may be no adequate remedy\nat law. In the event of a breach or threatened breach of any provision of such Section or Articles, the non-breaching Party shall be\nauthorized and entitled to seek from any court of competent jurisdiction injunctive relief, whether preliminary or permanent, specific\nperformance, and an equitable accounting of all earnings, profits, and other benefits arising from such breach, which rights shall be\n\n13.5 Severability. If any provision of this Agreement is held to be illegal, invalid, or unenforceable under\nany present or future law, and if the rights or obligations of either Party under this Agreement will not be materially and adversely\naffected thereby, (a) such provision shall be fully severable, (b) this Agreement shall be construed and enforced as if such illegal,\ninvalid, or unenforceable provision had never comprised a part hereof, (c) the remaining provisions of this Agreement shall remain in\nfull force and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance herefrom, and (d) in\nlieu of such illegal, invalid, or unenforceable provision, there shall be added automatically as a part of this Agreement a legal, valid, and\nenforceable provision as similar in terms to such illegal, invalid, or unenforceable provision as may be possible and reasonably"
}